Company Description
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user’s smartphone, tablet, and almost any hospital computer system; Butterfly iQ+ Bladder, a specialty product for the bladder scanning market; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians.
It also provides Butterfly system, which includes probes, related accessories, and software subscriptions to healthcare systems, physicians, and healthcare providers.
In addition, the company offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments; and ScanLab, an education-only app that provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process.
It sells its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
| Country | United States |
| Founded | 2011 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 190 |
| CEO | Joseph DeVivo |
Contact Details
Address: 1600 District Avenue Burlington, Massachusetts 01803 United States | |
| Phone | 781 557 4800 |
| Website | butterflynetwork.com |
Stock Details
| Ticker Symbol | BFLY |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001804176 |
| CUSIP Number | 124155102 |
| ISIN Number | US1241551027 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| Joseph M. DeVivo | Chief Executive Officer, President and Chairman of the Board |
| Dr. Jonathan M. Rothberg Ph.D. | Founder and Director |
| Steven Cashman | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 1, 2025 | 10-Q | Quarterly Report |
| Aug 1, 2025 | 8-K | Current Report |
| Jul 17, 2025 | SCHEDULE 13G | Filing |
| Jun 17, 2025 | SCHEDULE 13D/A | Filing |
| Jun 17, 2025 | 8-K | Current Report |
| May 5, 2025 | 144 | Filing |
| May 2, 2025 | 10-Q | Quarterly Report |
| May 2, 2025 | 8-K | Current Report |
| Apr 30, 2025 | ARS | Filing |
| Apr 30, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |